158 related articles for article (PubMed ID: 23419607)
21. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
[TBL] [Abstract][Full Text] [Related]
22. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(β-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
Mavreas KF; Neofytos DD; Chrysina ED; Venturini A; Gimisis T
Molecules; 2020 Nov; 25(22):. PubMed ID: 33266408
[TBL] [Abstract][Full Text] [Related]
24. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
Feuillastre S; Chajistamatiou AS; Potamitis C; Zervou M; Zoumpoulakis P; Chrysina ED; Praly JP; Vidal S
Bioorg Med Chem; 2012 Sep; 20(18):5592-9. PubMed ID: 22910227
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of anomeric sulfonamides and their behaviour under radical-mediated bromination conditions.
Czifrák K; Somsák L
Carbohydr Res; 2009 Feb; 344(3):269-77. PubMed ID: 19084827
[TBL] [Abstract][Full Text] [Related]
26. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
Varga G; Docsa T; Gergely P; Juhász L; Somsák L
Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
[TBL] [Abstract][Full Text] [Related]
29. Assessment of synthetic methods for the preparation of N-beta-d-glucopyranosyl-N'-substituted ureas, -thioureas and related compounds.
Somsák L; Felföldi N; Kónya B; Hüse C; Telepó K; Bokor E; Czifrák K
Carbohydr Res; 2008 Aug; 343(12):2083-93. PubMed ID: 18299124
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, In Silico and Kinetics Evaluation of
Homolya L; Mathomes RT; Varga L; Docsa T; Juhász L; Hayes JM; Somsák L
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731811
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
Zhang L; Chen X; Liu J; Zhu Q; Leng Y; Luo X; Jiang H; Liu H
Eur J Med Chem; 2012 Dec; 58():624-39. PubMed ID: 23178962
[TBL] [Abstract][Full Text] [Related]
32. Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
Kyriakis E; Solovou TGA; Kun S; Czifrák K; Szőcs B; Juhász L; Bokor É; Stravodimos GA; Kantsadi AL; Chatzileontiadou DSM; Skamnaki VT; Somsák L; Leonidas DD
Bioorg Chem; 2018 Apr; 77():485-493. PubMed ID: 29454281
[TBL] [Abstract][Full Text] [Related]
33. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
Liang Z; Zhang L; Li L; Liu J; Li H; Zhang L; Chen L; Cheng K; Zheng M; Wen X; Zhang P; Hao J; Gong Y; Zhang X; Zhu X; Chen J; Liu H; Jiang H; Luo C; Sun H
Eur J Med Chem; 2011 Jun; 46(6):2011-21. PubMed ID: 21439694
[TBL] [Abstract][Full Text] [Related]
34. C-(2-Deoxy-d-arabino-hex-1-enopyranosyl)-oxadiazoles: synthesis of possible isomers and their evaluation as glycogen phosphorylase inhibitors.
Bokor É; Szennyes E; Csupász T; Tóth N; Docsa T; Gergely P; Somsák L
Carbohydr Res; 2015 Aug; 412():71-9. PubMed ID: 26082971
[TBL] [Abstract][Full Text] [Related]
35. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
Bertus P; Szymoniak J; Jeanneau E; Docsa T; Gergely P; Praly JP; Vidal S
Bioorg Med Chem Lett; 2008 Sep; 18(17):4774-8. PubMed ID: 18701279
[TBL] [Abstract][Full Text] [Related]
37. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
Wen X; Zhang P; Liu J; Zhang L; Wu X; Ni P; Sun H
Bioorg Med Chem Lett; 2006 Feb; 16(3):722-6. PubMed ID: 16246555
[TBL] [Abstract][Full Text] [Related]
38. Identification of
Barr D; Szennyes E; Bokor É; Al-Oanzi ZH; Moffatt C; Kun S; Docsa T; Sipos Á; Davies MP; Mathomes RT; Snape TJ; Agius L; Somsák L; Hayes JM
ACS Chem Biol; 2019 Jul; 14(7):1460-1470. PubMed ID: 31243960
[TBL] [Abstract][Full Text] [Related]
39. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
[TBL] [Abstract][Full Text] [Related]
40. The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b.
Kantsadi AL; Hayes JM; Manta S; Skamnaki VT; Kiritsis C; Psarra AM; Koutsogiannis Z; Dimopoulou A; Theofanous S; Nikoleousakos N; Zoumpoulakis P; Kontou M; Papadopoulos G; Zographos SE; Komiotis D; Leonidas DD
ChemMedChem; 2012 Apr; 7(4):722-32. PubMed ID: 22267166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
